Pediatric Oseltamivir Dosing Based on Weight
For children ≥12 months old, oseltamivir dosing is weight-based: ≤15 kg receive 30 mg, >15-23 kg receive 45 mg, >23-40 kg receive 60 mg, and >40 kg receive 75 mg, all given twice daily for treatment (5 days) or once daily for prophylaxis (10 days). 1, 2, 3
Weight-Based Dosing for Children ≥12 Months
The most current AAP guidelines provide clear weight-based dosing tiers:
- ≤15 kg (≤33 lb): 30 mg twice daily for treatment / 30 mg once daily for prophylaxis
- >15-23 kg (33-51 lb): 45 mg twice daily for treatment / 45 mg once daily for prophylaxis
- >23-40 kg (>51-88 lb): 60 mg twice daily for treatment / 60 mg once daily for prophylaxis
- >40 kg (>88 lb): 75 mg twice daily for treatment / 75 mg once daily for prophylaxis
Infants <12 Months
For infants 9-11 months: 3.5 mg/kg per dose twice daily for treatment, once daily for prophylaxis 1, 2, 3
For term infants 0-8 months: 3 mg/kg per dose twice daily for treatment. For prophylaxis, 3 mg/kg once daily is recommended only for infants 3-8 months; prophylaxis is not recommended for infants <3 months unless the situation is judged critical due to limited safety and efficacy data. 1, 2, 3
Important Caveat for Infants 9-11 Months
The AAP-recommended dose of 3.5 mg/kg twice daily for infants 9-11 months is higher than the FDA-approved dose of 3.0 mg/kg twice daily. This higher dose is based on pharmacokinetic data showing that infants in this age group require the increased dose to achieve target drug exposures. The CDC recommends 3.0 mg/kg for all infants <12 months, creating a discrepancy between AAP and CDC guidance. 2, 3
Preterm Infants
Preterm infants require lower doses than term infants due to immature renal function. Dosing is based on postmenstrual age (PMA = gestational age + chronologic age):
- <38 weeks PMA: 1.0 mg/kg per dose twice daily
- 38-40 weeks PMA: 1.5 mg/kg per dose twice daily
- >40 weeks PMA: 3.0 mg/kg per dose twice daily
For extremely preterm infants (<28 weeks), consult a pediatric infectious disease specialist. Prophylaxis is generally not recommended for preterm infants due to limited data. 1, 2, 3
Formulation and Administration
Oseltamivir is available as:
- Capsules: 30 mg, 45 mg, 75 mg
- Oral suspension: 6 mg/mL concentration (after reconstitution)
For the 6 mg/mL suspension:
- 30 mg dose = 5 mL
- 45 mg dose = 7.5 mL
- 60 mg dose = 10 mL
- 75 mg dose = 12.5 mL
For infants <1 year, use an appropriate measuring device (such as a 3-mL or 5-mL oral syringe) rather than the syringe supplied with the medication to ensure accurate dosing. 3, 4
Administration with food may improve gastrointestinal tolerability, though it can be given without regard to meals. 1, 2, 3, 4
Treatment Duration
- Treatment: 5 days for all age groups
- Prophylaxis: 10 days for post-exposure prophylaxis; up to 6 weeks for seasonal prophylaxis (or up to 12 weeks in immunocompromised patients)
Renal Dosing Considerations
In patients with renal insufficiency, dose adjustment is required based on creatinine clearance. For pediatric patients >40 kg who qualify for adult dosing, refer to published CDC dosing tables for renal adjustment. 3, 4